Abstract
The purpose of this study is to evaluation the effect of tumor volume and radiotherapy on the uptake of 18F-2-fluoro-2-deoxy-D-glucose (18FDG). The tumor models used were mouse mammary carcinoma MM48, FM3A, and rat hepatoma AH109A. Results were expressed as an 18FDG uptake ratio. This was the ratio of irradiated tumor uptake of 18FDG to unirradiated tumor uptake. The total tumor uptake was expressed as 18FDG uptake ratio multiplied by relative tumor volume. Following 20 Gy irradiation of the radioresistant tumor (MM48), the 18FDG uptake ratio was found to be unchanged, whereas in radiosensitive tumors (FM3A) the 18FDG uptake ratio was 0.37, the relative tumor volume was 0.31, and the calculated total tumor uptake was 0.11 on the eighth day after irradiation. The total tumor uptake was lower than the relative tumor volume. AH109A began to regrow after ten Gy irradiation, accompanied by elevated uptake of 18FDG on the seventh day. These results suggest that the 18FDG uptake by tumor is a good marker of radiotherapeutic effects as well as relapses of cancers and is more sensitive than morphological methods.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Di Chiro G, DeLapaz, RL, Brooks RA, Sokoloff, L, Kornblith, PL, Smith BH, Patronas NJ, Kufta CV, Kessler RM, Johnston GS, Manning RG, Wolf AP (1982) Glucose utilization of cerebral gliomas measured by 18F-fluorodeoxyglucose and positron emission tomography. Neurology 32:1323–1329
Fukuda H, Matsuzawa T, Abe Y, Endo S, Yamada K, Kubota K, Hatazawa J, Sato T, Ito M, Takahashi T, Iwata R, Ido T (1982) Experimental study for cancer diagnosis with positronlabeled fluorinated glucose analogs: 18F-2-fluoro-2-deoxy-D-mannose: a new tracer for cancer detection. Eur J Nucl Med 7:294–297
Ido T, Wan CN, Casella V, Fowler JS, Wolf AP, Reivich M, Kuhl D (1978) Labeled-2-deoxy-2-fluoro-D-glucose analogs. 18F-labeled-2-deoxy-2-fluoro-D-glucose, 2-deoxy-2-fluoro-D-mannose and 14-2-deoxy-2-fluoro-D-glucose. J Labeld Compd Radiopharma XIV:175–183
Iosilevsky G, Front D, Bettman L, Hardoff R, Ben-Arieh Y (1985) Uptake of Gallium-67 citrate and [2-3H]-deoxyglucose in the tumor model, following chemotherapy and radiotherapy. J Nucl Med 26:278–282
Som P, Atkins HL, Bandoypadhyay, D, Fowler JS, McGregor RR, Matsui K, Oster ZH, Sacker DF, Shiue CY, Turner H, Wan C-N, Wolf AP, Zabinski SV (1980) A Fluorinated glucose analog 2-fluoro-2-deoxy-D-glucose (F-18): Nontoxic tracer for rapid tumor detection. J Nucl Med 21:670–675
Yonekura Y, Benua RS, Brill AB, Som P, Yeh SDJ, Kemeny NE, Fowler JS, MacGregor RR, Stamm R, Christman DR, Wolf AP (1982) Increased accumulation of 2-deoxy-2-18F-fluoro-D-glucose in liver metastases from colon carcinoma. J Nucl Med 23:1133–1137
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Abe, Y., Matsuzawa, T., Fujiwara, T. et al. Assessment of radiotherapeutic effects on experimental tumors using 18F-2-fluoro-2-deoxy-D-glucose. Eur J Nucl Med 12, 325–328 (1986). https://doi.org/10.1007/BF00263812
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00263812